Jin-hong Chen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM (NCT06455254) | Jin-hong Chen | 2024-07-11 |
Track Jin-hong Chen automatically
Every clearance here is in the API, with alerts when new ones post.